[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=78884]], camposKey:1578-1879 2023-01-01 Actualización y validación del riesgo cardiovascular: comunicación corta142143, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75157]], camposKey:0214-9168 2022-05-01 SEA 2022 Standards for Global Control of Cardiovascular Risk130179, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70617]], camposKey:1578-1879 2022-01-01 Estándares SEA 2022 para el control global del riesgo cardiovascular130179, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65159]], camposKey:0014-2565 2021-12-01 Estimation of vascular risk: time and place matter Estimación del riesgo vascular. El tiempo y el lugar importan596597, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=64727]], camposKey:0014-2565 2021-01-01 Estimación del riesgo vascular: el tiempo y el lugar importan596597, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73065]], camposKey:0014-2565 2018-12-01 Clinical ultrasonography and abdominal aortic aneurysms in Internal Medicine477478, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73082]], camposKey:1885-5857 2018-05-01 Vascular Age, RR, ALLY, RALLY and Vascular Speed, Based on SCORE: Relations Between New Concepts of Cardiovascular Prevention399400, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43662]], camposKey:0014-2565 2018-01-01 Ecografía clínica y aneurisma de aorta abdominal en Medicina Interna477478, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43660]], camposKey:0300-8932 2018-01-01 Edad vascular, RR, ALLY, RALLY y velocidad de envejecimiento, basados en el SCORE: relaciones entre nuevos conceptos de prevención cardiovascular399400, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73089]], camposKey:2047-4873 2016-11-01 Vascular age calculation and equivalent risk factors in HIV-infected patients obtained from the D:A:D risk equation19031908, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73060]], camposKey:0214-9168 2016-07-01 Vascular risk in endocrine diseases other than diabetes197201, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73069]], camposKey:0214-9168 2016-03-01 Cardiovascular disease and systemic inflammatory diseases94101, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73080]], camposKey:1885-5857 2016-03-01 Vascular Age Versus Cardiovascular Risk: Clarifying Concepts243246, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43664]], camposKey:0214-9168 2016-01-01 Enfermedades cardiovasculares y enfermedades inflamatorias sistémicas94101, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43661]], camposKey:0300-8932 2016-01-01 La edad vascular frente al riesgo cardiovascular: aclarando conceptos243246, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43658]], camposKey:0214-9168 2016-01-01 Riesgo vascular en enfermedades endocrinológicas distintas a la diabetes197201, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73098]], camposKey:0953-6205 2015-07-01 Hyperglycemia management in patients admitted to internal medicine in Spain: A point-prevalence survey examining adequacy of glycemic control and guideline adherence392398, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73081]], camposKey:0025-7753 2015-06-08 Usefulness of measuring cardiovascular risk at 30 years and vascular age526527, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73083]], camposKey:0025-7753 2015-05-01 Primary cardiovascular prevention with statins in type 2 diabetes mellitus431432, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73088]], camposKey:0014-2565 2015-01-01 Cardiovascular news 2013/20143342, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43659]], camposKey:0014-2565 2015-01-01 Novedades cardiovasculares 2013/20143342, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73096]], camposKey:1471-2261 2014-12-18 Unanswered clinical questions in the management of cardiometabolic risk in the elderly: a statement of the Spanish society of internal medicine00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73076]], camposKey:0306-9877 2014-06-01 Interaction of genes and nutritional factors in the etiology of autism and attention deficit/hyperactivity disorders: A case control study654661, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73075]], camposKey:0014-2565 2013-12-01 What was new about vascular risk in the year 2012?442452, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73099]], camposKey:0025-7753 2013-03-16 Vascular risk in outpatient from Internal Medicine departments. MICARE Study246254, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73074]], camposKey:1885-5857 2013-03-01 Vascular Age Derived From SCORE and the European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)241241, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43654]], camposKey:0214-9168 2013-01-01 Cardiopatía isquémica203210, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43666]], camposKey:0014-2565 2013-01-01 ¿Qué ha habido de nuevo en riesgo vascular en el año 2012?442452, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73092]], camposKey:0953-6205 2012-09-01 Metabolic syndrome and vascular risk estimation in a Mediterranean non-diabetic population without cardiovascular disease558563, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73100]], camposKey:0742-3071 2011-06-01 Blood glucose control and quality of health care in non-insulin-treated patients with Type 2 diabetes in Spain: a retrospective and cross-sectional observational study731740, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43663]], camposKey:1889-1837 2011-01-01 Riesgo vascular121125, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73070]], camposKey:0195-668X 2010-10-01 How to calculate vascular age with the SCORE project scales: a new method of cardiovascular risk evaluation23512358, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73072]], camposKey:0263-6352 2010-06-01 EFFECT OF CONTROLLING BLOOD PRESSURE, HYPERCHOLESTEROLEMIA OR SMOKING ON VASCULAR AGE00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73101]], camposKey:0953-6205 2009-07-01 Thigh and buttock exertional pain for the diagnosis of peripheral arterial disease429434, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73102]], camposKey:0025-7753 2008-11-01 Prevalence of asymptomatic peripheral artery disease detected by the ankle-brachial index in patients with cardiovascular disease. MERITO II study561565, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73097]], camposKey:0953-6205 2008-06-01 Sub-clinical vascular disease in type 2 diabetic subjects: Relationship with chronic complications of diabetes and the presence of cardiovascular disease risk factors255260, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73067]], camposKey:1600-6135 2007-06-01 Effect of population aging on the international organ donation rates and the effectiveness of the donation process15261535, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73068]], camposKey:0025-7753 2007-03-10 Comparison of the SCORE function chart and the Framingham-REGICOR equation to estimate the cardiovascular risk358358, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73086]], camposKey:0014-2565 2007-03-01 Effect of a global intervention in the integral control of multiple risk factors in patients at high or very high cardiovascular risk. CIFARC 2 project112120, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43656]], camposKey:0014-2565 2007-01-01 Efecto de una intervención global sobre el control integral de múltiples factores de riesgo en pacientes con alto o muy alto riesgo cardiovascular. Estudio CIFARC 2112120, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=60174]], camposKey:0014-2565 2007-01-01 Prevalence of peripheral artery disease evaluated by ankle brachial index in patients with metabolic syndrome. MERITO I study Prevalencia de enfermedad arterial periférica estimada mediante el índice tobillo-brazo en pacientes con síndrome metabólico. Estudio MERITO I228233, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43665]], camposKey:1135-5727 2006-01-01 La adopción de los percentiles de riesgo cardiovascular evita la sobreestimación o infraestimación del riesgo cardiovascular calculado con el SCORE125138, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43653]], camposKey:0214-9168 2006-01-01 Percentiles de riesgo coronario: una nueva forma de adaptar las escalas de riesgo. Estudio ERVPA218225, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73095]], camposKey:0025-7753 2005-01-22 Integral control of risk factors in patients of high and very high cardiovascular risk in Spain. CIFARC project4449, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43655]], camposKey:0025-7753 2005-01-01 Control integral de los factores de riesgo en pacientes de alto y muy alto riesgo cardiovascular en España: Estudio CIFARC4449, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73063]], camposKey:0025-7753 2004-06-26 Risk percentiles: a new adapted method for evaluating vascular risk. ERVPA study121126, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43657]], camposKey:0025-7753 2004-01-01 Percentiles de riesgo: un nuevo método adaptado para la valoración del riesgo vascular. Estudio ERVPA121126, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73062]], camposKey:0025-7753 2003-09-27 Different approach in high-cardiovascular-risk women, compared to men398398, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=50775]], camposKey:0014-2565 2001-01-01 Study of cases of HIV infection in Castile-Leon prisons249255, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73078]], camposKey:0025-7753 1999-11-06 Stachydrin, quails and biblic plagues599599, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73079]], camposKey:0025-7753 1999-02-06 Epidemic rhabdomyolysis by quails ingestion. A clinical, epidemiologic and experimental study143146, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=78253]], camposKey:0025-7753 1999-01-01 Rabdomiólisis epidémica por ingestión de codornices: estudio clínico, epidemiológico y experimental143146, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73091]], camposKey:0025-7753 1998-11-28 The relationship between viral load, CD4+ lymphocyte count and duration of HIV infection717718, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73064]], camposKey:0025-7753 1995-05-27 FALSE MELANURIA IN A PATIENT TREATED WITH 5-ASA FOR ULCERATIVE CHOLITIS798798, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73061]], camposKey:0025-7753 1995-02-18 SPECIFIC AND FAST TYPING OF CLINICAL ISOLATES OF MYCOBACTERIUM BY PCR AND RESTRICTION ENZYME ANALYSIS207210, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73077]], camposKey:0146-6615 1994-06-01 HIGH PREVALENCE OF HHV-6 DNA IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF HEALTHY-INDIVIDUALS DETECTED BY NESTED-PCR115118, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73084]], camposKey:0025-7753 1993-01-23 HHV-6 IN DRUG-ADDICTS AND HIV115116, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73094]], camposKey:0042-9007 1993-01-01 HTLV-I AND HTLV-II INFECTIONS IN SPAIN5960, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73071]], camposKey:0025-7753 1992-09-12 MONOCYTIC DYSFUNCTION BY OPIOID-PEPTIDES IN PATIENTS WITH MAJOR DEPRESSION241243, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73093]], camposKey:0270-9139 1992-09-01 HEPATITIS-B AND HEPATITIS-C VIRAL-INFECTIONS IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA637641, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73073]], camposKey:0014-2565 1991-03-01 CHRONIC ASTHENIA SYNDROME AND VIRAL-INFECTIONS257262, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73090]], camposKey:0042-9007 1991-01-01 HUMAN HERPESVIRUS 6 IN SPAIN - SEROPREVALENCE IN BLOOD-DONORS AND PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS OR HIV-INFECTION6364, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73087]], camposKey:0025-7753 1990-05-19 HUMAN HERPESVIRUS TYPE-6 AND CHRONIC ASTHENIA SYNDROME721724, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=81304]], camposKey:0025-7753 1990-01-01 Virus herpes humano tipo 6 y síndrome de astenia crónica721724, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73085]], camposKey:0014-2565 1989-04-01 MIXED CRYOGLOBULINEMIA AND NON-A, NON-B CHRONIC HEPATITIS390391, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73066]], camposKey:0025-7753 1989-02-11 PREVALENCE OF ANTIBODIES AGAINST HUMAN HERPESVIRUS 6(VHH-6 OR HBLV) IN THE GENERAL-POPULATION199199][][][][][][][][][][][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145629495]]][][][][][][][][][][][][][][][][][][][][][][][][com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@142ad][]